Literature DB >> 8386511

PPAR-RXR heterodimer activates a peroxisome proliferator response element upstream of the bifunctional enzyme gene.

O Bardot1, T C Aldridge, N Latruffe, S Green.   

Abstract

A DNA sequence that confers a response to a class of rodent hepatocarcinogens termed peroxisome proliferators has been identified 2947bp upstream of the rat peroxisomal bifunctional enzyme gene. Two members of the steroid hormone receptor family, termed the peroxisome proliferator activated receptor (PPAR alpha) and the retinoid X receptor (RXR alpha), co-operate to bind specifically to this sequence. Importantly, this response element (PPRE) is similar to that identified upstream of other peroxisome proliferator responsive genes such as those encoding acyl CoA oxidase and cytochrome P450 IVA6. These data therefore provide further evidence that PPAR alpha plays an important role in mediating the action of peroxisome proliferators.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8386511     DOI: 10.1006/bbrc.1993.1378

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  52 in total

1.  A comparative study of genome-wide transcriptional profiles of primary hepatocytes in collagen sandwich and monolayer cultures.

Authors:  Yeonhee Kim; Christopher D Lasher; Logan M Milford; T M Murali; Padmavathy Rajagopalan
Journal:  Tissue Eng Part C Methods       Date:  2010-06-07       Impact factor: 3.056

2.  CYP4A1 gene transfection studies and the peroxisome proliferator-activated receptor: development of a high-throughput assay to detect peroxisome proliferators.

Authors:  S J Giddings; S E Clarke; G G Gibson
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1997 Oct-Dec       Impact factor: 2.441

3.  Molecular cloning of a peroxisomal Ca2+-dependent member of the mitochondrial carrier superfamily.

Authors:  F E Weber; G Minestrini; J H Dyer; M Werder; D Boffelli; S Compassi; E Wehrli; R M Thomas; G Schulthess; H Hauser
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-05       Impact factor: 11.205

4.  Peroxisome proliferator-activated receptor-α activation promotes macrophage reverse cholesterol transport through a liver X receptor-dependent pathway.

Authors:  Kazuhiro Nakaya; Junichiro Tohyama; Snehal U Naik; Hiroyuki Tanigawa; Colin MacPhee; Jeffrey T Billheimer; Daniel J Rader
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-03-24       Impact factor: 8.311

5.  Hepatocyte proliferation induced by a single dose of a peroxisome proliferator.

Authors:  T Ohmura; G M Ledda-Columbano; R Piga; A Columbano; J Glemba; S L Katyal; J Locker; H Shinozuka
Journal:  Am J Pathol       Date:  1996-03       Impact factor: 4.307

6.  Differential inhibition of macrophage foam-cell formation and atherosclerosis in mice by PPARalpha, beta/delta, and gamma.

Authors:  Andrew C Li; Christoph J Binder; Alejandra Gutierrez; Kathleen K Brown; Christine R Plotkin; Jennifer W Pattison; Annabel F Valledor; Roger A Davis; Timothy M Willson; Joseph L Witztum; Wulf Palinski; Christopher K Glass
Journal:  J Clin Invest       Date:  2004-12       Impact factor: 14.808

7.  Liver fatty acid-binding protein: specific mediator of the mitogenesis induced by two classes of carcinogenic peroxisome proliferators.

Authors:  S H Khan; S Sorof
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-01       Impact factor: 11.205

8.  A human hepatocyte-bearing mouse: an animal model to predict drug metabolism and effectiveness in humans.

Authors:  Katsutoshi Yoshizato; Chise Tateno
Journal:  PPAR Res       Date:  2009-10-26       Impact factor: 4.964

Review 9.  Modulation of mitogenesis by liver fatty acid binding protein.

Authors:  S Sorof
Journal:  Cancer Metastasis Rev       Date:  1994-12       Impact factor: 9.264

10.  Liver x receptor: a novel therapeutic target.

Authors:  M B Patel; N A Oza; I S Anand; S S Deshpande; C N Patel
Journal:  Indian J Pharm Sci       Date:  2008 Mar-Apr       Impact factor: 0.975

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.